Funding the best brains to beat brain cancer

Brain cancer kills more children in Australia than any other disease and more people under 40 than any other cancer.  The worst type of brain cancer, GBM, is also the most common and has an average survival of only 15 months from diagnosis.

As a neurosurgeon I have operated on patients from all around the world who have been given no hope. At the Charlie Teo Foundation, we fund game-changing brain cancer research, offering hope of a better future for patients and families.

We need to start thinking differently to find a solution.

"Let’s do this together. We are going to get there. A world without brain cancer."

Dr Charlie Teo AM – Founder

Our Impact

Committed $7.5 million
to brain cancer research

in Australia and worldwide

Supporting 20 brain cancer
research projects
in adult & childhood brain cancer

Most disruptive and transparent Australian charity funding brain cancer research

Runs low-cost with
total costs < 20% of total income.
We keep our overheads lean!

Committed $9 million
to brain cancer research

in Australia and worldwide

Supporting over 20
brain cancer
research projects
in adult & childhood brain cancer

Most disruptive and transparent Australian charity funding brain cancer research

Runs low-cost with
total costs < 20% of total income.
We keep our overheads lean!

Thank you to our corporate partners

Your investment in our ground-breaking research is making a genuine difference to people impacted by brain cancer

Upcoming Events

Ask Charlie

Webseries

Conversations with Charlie

Podcasts

Sandy Point Half Marathon

Sandy Point, VIC

Sandy Point Half Marathon

Sandy Point, VIC

28th November 2021

Blackmores Running Festival

Sydney, NSW

14th August 2022

Hobart Airport Marathon

Hobart, TAS

25th September 2022

Charlie and the Chocolate Ball

Adelaide, SA

15th October 2022

Latest News

Keep up to date with our latest game-changing research and fundraising events.

Keep up to date with our latest game-changing research and fundraising events.